Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 14.03
(1.08%)
CNY 14.03
(1.08%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 17.93 Billion CNY | -14.8% |
| 2022 | 21.05 Billion CNY | 35.03% |
| 2021 | 15.59 Billion CNY | 25.77% |
| 2020 | 12.39 Billion CNY | 15.34% |
| 2019 | 10.75 Billion CNY | 0.79% |
| 2018 | 10.66 Billion CNY | 44.33% |
| 2017 | 7.38 Billion CNY | 29.25% |
| 2016 | 5.71 Billion CNY | 149.44% |
| 2015 | 2.29 Billion CNY | 106.74% |
| 2014 | 1.1 Billion CNY | 36.63% |
| 2013 | 811.49 Million CNY | 14.92% |
| 2012 | 706.14 Million CNY | 17.56% |
| 2011 | 600.69 Million CNY | 156.43% |
| 2010 | 234.25 Million CNY | 31.09% |
| 2009 | 178.68 Million CNY | 61.25% |
| 2008 | 110.81 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 17.54 Billion CNY | -1.73% |
| 2024 Q3 | 17.07 Billion CNY | -2.69% |
| 2024 Q1 | 17.85 Billion CNY | -0.47% |
| 2023 FY | 17.93 Billion CNY | -14.8% |
| 2023 Q4 | 17.93 Billion CNY | -4.3% |
| 2023 Q1 | 21.16 Billion CNY | 0.5% |
| 2023 Q3 | 18.74 Billion CNY | -5.23% |
| 2023 Q2 | 19.78 Billion CNY | -6.53% |
| 2022 Q3 | 21.07 Billion CNY | 1.01% |
| 2022 Q1 | 17.54 Billion CNY | 12.51% |
| 2022 FY | 21.05 Billion CNY | 35.03% |
| 2022 Q4 | 21.05 Billion CNY | -0.09% |
| 2022 Q2 | 20.86 Billion CNY | 18.93% |
| 2021 Q3 | 15.34 Billion CNY | 9.2% |
| 2021 Q1 | 13.37 Billion CNY | 7.84% |
| 2021 FY | 15.59 Billion CNY | 25.77% |
| 2021 Q4 | 15.59 Billion CNY | 1.64% |
| 2021 Q2 | 14.04 Billion CNY | 5.07% |
| 2020 Q2 | 12.43 Billion CNY | 15.13% |
| 2020 Q1 | 10.8 Billion CNY | 0.47% |
| 2020 FY | 12.39 Billion CNY | 15.34% |
| 2020 Q3 | 12.65 Billion CNY | 1.79% |
| 2020 Q4 | 12.39 Billion CNY | -2.05% |
| 2019 Q1 | 10.68 Billion CNY | 0.21% |
| 2019 FY | 10.75 Billion CNY | 0.79% |
| 2019 Q2 | 11.09 Billion CNY | 3.77% |
| 2019 Q3 | 10.8 Billion CNY | -2.58% |
| 2019 Q4 | 10.75 Billion CNY | -0.51% |
| 2018 Q3 | 9.19 Billion CNY | 1.06% |
| 2018 Q2 | 9.09 Billion CNY | 24.55% |
| 2018 Q1 | 7.3 Billion CNY | -1.17% |
| 2018 FY | 10.66 Billion CNY | 44.33% |
| 2018 Q4 | 10.66 Billion CNY | 16.03% |
| 2017 FY | 7.38 Billion CNY | 29.25% |
| 2017 Q2 | 6.25 Billion CNY | 8.32% |
| 2017 Q3 | 6.87 Billion CNY | 9.99% |
| 2017 Q1 | 5.77 Billion CNY | 0.94% |
| 2017 Q4 | 7.38 Billion CNY | 7.47% |
| 2016 Q3 | 5.24 Billion CNY | 28.37% |
| 2016 Q1 | 3.2 Billion CNY | 39.81% |
| 2016 FY | 5.71 Billion CNY | 149.44% |
| 2016 Q4 | 5.71 Billion CNY | 9.03% |
| 2016 Q2 | 4.08 Billion CNY | 27.47% |
| 2015 Q2 | 1.62 Billion CNY | 21.45% |
| 2015 Q1 | 1.33 Billion CNY | 20.84% |
| 2015 Q3 | 2.09 Billion CNY | 29.05% |
| 2015 Q4 | 2.29 Billion CNY | 9.16% |
| 2015 FY | 2.29 Billion CNY | 106.74% |
| 2014 FY | 1.1 Billion CNY | 36.63% |
| 2014 Q4 | 1.1 Billion CNY | 22.93% |
| 2014 Q1 | 775.17 Million CNY | -4.48% |
| 2014 Q3 | 901.9 Million CNY | -0.19% |
| 2014 Q2 | 903.62 Million CNY | 16.57% |
| 2013 Q4 | 811.49 Million CNY | -0.7% |
| 2013 Q2 | 796.98 Million CNY | 8.93% |
| 2013 Q1 | 731.61 Million CNY | 3.61% |
| 2013 FY | 811.49 Million CNY | 14.92% |
| 2013 Q3 | 817.19 Million CNY | 2.54% |
| 2012 Q2 | 672.41 Million CNY | 10.88% |
| 2012 Q1 | 606.44 Million CNY | 0.96% |
| 2012 Q3 | 670.44 Million CNY | -0.29% |
| 2012 FY | 706.14 Million CNY | 17.56% |
| 2012 Q4 | 706.14 Million CNY | 5.32% |
| 2011 Q3 | 561.75 Million CNY | 93.5% |
| 2011 Q4 | 600.69 Million CNY | 6.93% |
| 2011 Q2 | 290.31 Million CNY | 19.94% |
| 2011 Q1 | 242.03 Million CNY | 3.32% |
| 2011 FY | 600.69 Million CNY | 156.43% |
| 2010 Q4 | 234.25 Million CNY | 0.0% |
| 2010 FY | 234.25 Million CNY | 31.09% |
| 2009 FY | 178.68 Million CNY | 61.25% |
| 2008 FY | 110.81 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Hangzhou Tigermed Consulting Co., Ltd. | 29.69 Billion CNY | 39.593% |
| Dirui Industrial Co.,Ltd. | 3.32 Billion CNY | -440.216% |
| Beijing Strong Biotechnologies, Inc. | 5.17 Billion CNY | -246.603% |
| Medicalsystem Biotechnology Co., Ltd. | 3.48 Billion CNY | -414.14% |
| Maccura Biotechnology Co.Ltd | 8.11 Billion CNY | -120.948% |
| Guangzhou Wondfo Biotech Co.,Ltd | 5.77 Billion CNY | -210.814% |
| Guangdong Hybribio Biotech Co.,Ltd. | 5.72 Billion CNY | -213.307% |
| BGI Genomics Co., Ltd. | 13.61 Billion CNY | -31.781% |
| Amoy Diagnostics Co., Ltd. | 1.93 Billion CNY | -827.153% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 2.98 Billion CNY | -500.608% |